Skip to main content

Complications

Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.

On March 18, NeuroMetrix launched the second-generation version of its Sensus pain management device, The Sensus is designed to relieve the pain and numbness often...
At the end of March, encouraging news about Takeda’s once-daily pill for type 2 diabetes, Nesina (alogliptin), circulated at the American College of Cardiology (ACC)...
The consensus from most speakers at the workshop was that, while this possible link does require further investigation, the available evidence does not suggest any need...
On June 11, Glooko and the Joslin Diabetes Center announced the release of their HypoMap software , a cool product that really should be able to identify and help...
The curious milestone of a diabetes anniversary.
In February, Johnson and Johnson announced that its SGLT-2 inhibitor for type 2 diabetes, Invokana (canagliflozin), will undergo trials as a treatment for diabetic...
Update (1/12/15): Medtronic Diabetes gave an update on their upcoming diabetes device pipeline at the J.P. Morgan Healthcare Conference. The MiniMed 640G is expected to...
How these two FDA-submitted drugs could address this major healthcare need.
Over seven million Americans have diabetic retinopathy – how Eylea provides another treatment for this serious complication.
$300 million and counting – how much have we learned from the heart safety trials of Onglyza and Nesina?
Our deep dive on a new therapy now available in Europe – the benefits, risks, and when it might come to the US.
How this new option makes it easier to diagnose this major diabetes complication.
How a major research study is challenging an outdated FDA restriction.
Why these two seemingly different diseases may be more similar than you think.
By Kelly Close Twitter Summary: @kellyclose speaks to @US_FDA in favor of PCSK9 inhibitor drug Praluent – need to bring more options to #PWD to fight against CV disease...
Can a drug long-used to treat gout be effective at preventing diabetic kidney disease?
One of the highlights of this year’s ADA Exhibit Hall was NeuroMetrix’s Quell chronic pain management device. Quell is the over the counter version (no prescription...
Expansion of the use of Roche’s Lucentis a major step for patients.
How will a new drug fare in a 4,000-patient, four-year study?
Our overview of what all of us need to know about one of our most vital organs – our kidneys.

Pages